(Reuters) - Actavis Plc on Monday said it has sued the U.S. Food and Drug Administration, challenging its decision to award exclusive rights to Teva Pharmaceutical Industries Ltd to sell a generic version of Pfizer Inc's blockbuster painkiller Celebrex. The move follows a similar lawsuit announced Friday by Mylan Inc over generic drug marketing exclusivity for Celebrex. (Reporting by Susan Kelly in Chicago; Editing by Bernard Orr)
via Health News Headlines - Yahoo News
Read More Here.. 
Lake forest health and fitness http://ift.tt/1ivf0v8
No comments:
Post a Comment